U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
160321160321A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.TerminatedNo Results AvailableHepatitis B, ChronicDrug: peginterferon alfa-2a (40KD) [PEGASYS]https://ClinicalTrials.gov/show/NCT00460850
160322160322Comparison of Bowel Preparation in Virtual Colonoscopy (VC) - Patient ExperienceWithdrawnNo Results AvailableColorectal CancerDrug: bowel preparation: senna & gastrofin versus picolax (standard)https://ClinicalTrials.gov/show/NCT00460837
160323160323A Retrospective Review - Anti-HLA AntibodiesWithdrawnNo Results AvailableCongenital Disordershttps://ClinicalTrials.gov/show/NCT00460824
160324160324Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)CompletedHas ResultsIrritable Bowel Syndrome With ConstipationDrug: Linaclotide Acetate|Drug: Matching placebohttps://ClinicalTrials.gov/show/NCT00460811
160325160325SUTENT® In The First Line Treatment Of Renal Cell CarcinomaCompletedHas ResultsRenal Cell CarcinomaOther: Sutent: observational studyhttps://ClinicalTrials.gov/show/NCT00460798
160326160326Bioequivalence Trial of a New Opioid Combination Compared to ReferenceCompletedNo Results AvailableHealthyDrug: Opioidhttps://ClinicalTrials.gov/show/NCT00460785
160327160327Pharmacokinetic Issues of Moxifloxacin Plus RifapentineActive, not recruitingNo Results AvailableMycobacterium TuberculosisDrug: Moxifloxacin|Drug: Rifapentinehttps://ClinicalTrials.gov/show/NCT00460759
160328160328Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.CompletedHas ResultsHIVDrug: TMC125, Darunavir; Ritonavirhttps://ClinicalTrials.gov/show/NCT00460746
160329160329SOLID-Effect of Risedronate Sodium at Distal Radius in Colle's Fracture.CompletedNo Results AvailableColles' FractureDrug: Risedronate sodium|Drug: Calcium & Vitamine D3https://ClinicalTrials.gov/show/NCT00460733
160330160330Compliance Survey of ADHD Medication for Optimal Satisfaction (COSMOS)CompletedNo Results AvailableAttention Deficit Disorder With HyperactivityOther: Observational treatment compliance surveyhttps://ClinicalTrials.gov/show/NCT00460720
160331160331A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy AdultsCompletedNo Results AvailableHealthy Subjects|Nausea and Vomiting, Chemotherapy-InducedDrug: Casopitant|Drug: Ketoconazolehttps://ClinicalTrials.gov/show/NCT00460707
160332160332Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological MalignanciesCompletedNo Results AvailableAcute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Chronic Myeloid Leukemia|Non Hodgkin's Lymphoma|Hodgkin's Disease|Myelodysplastic Syndrome|Multiple MyelomaBiological: infusion of allogeneic CIK cellshttps://ClinicalTrials.gov/show/NCT00460694
160333160333Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular CarcinomaRecruitingNo Results AvailableHepatocellular CarcinomaDrug: Thymopentinhttps://ClinicalTrials.gov/show/NCT00460681
160334160334The Effect of Post-thoracotomy Pulmonary Rehabilitation on Quality of LifeCompletedNo Results AvailableLung Cancer|Thoracotomy|Pulmonary RehabilitationBehavioral: pulmonary rehabilitationhttps://ClinicalTrials.gov/show/NCT00460668
160335160335Study of GSK1358820 In Patients With Post-Stroke Lower Limb SpasticityCompletedHas ResultsPost-Stroke Spasticity|Cerebrovascular AccidentDrug: GSK1358820|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00460655
160336160336GnRH Antagonist to Prepare Recipients for Embryo TransferCompletedNo Results AvailableInfertilityDrug: GnRH Antagonist (Cetrotide)https://ClinicalTrials.gov/show/NCT00460642
160337160337Prophylactic Transfer of Leukemia-reactive T Cells After Allogeneic TransplantationCompletedNo Results AvailableChronic Myeloid LeukemiaProcedure: Application of activated donor T cellshttps://ClinicalTrials.gov/show/NCT00460629
160338160338Cardiac Valve Complications in Prolactinomas Treated With CabergolineCompletedNo Results AvailableProlactinomasDrug: Cabergolinehttps://ClinicalTrials.gov/show/NCT00460616
160339160339Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal CancerCompletedHas ResultsColorectal NeoplasmsDrug: bevacizumab|Drug: AG-013726|Drug: AG-013736 (axitinib)https://ClinicalTrials.gov/show/NCT00460603
160340160340Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape TownCompletedNo Results AvailableTuberculosisBiological: MVA 85Ahttps://ClinicalTrials.gov/show/NCT00460590
160341160341Efficacy of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Children (5- - CompletedHas ResultsAcute Bronchial Obstruction, AsthmaDrug: Formoterol fumerate|Drug: fenoterol/ipratropium bromidehttps://ClinicalTrials.gov/show/NCT00460577
160342160342Study Of GSK1358820 In Patients With Post-Stroke Upper Limb SpasticityCompletedHas ResultsPost-Stroke Spasticity|Cerebrovascular AccidentDrug: GSK1358820|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00460564
160343160343Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung CancerTerminatedHas ResultsNon Small Cell Lung CancerBiological: Zalutumumab|Drug: Induction chemotherapy|Radiation: Radiotherapyhttps://ClinicalTrials.gov/show/NCT00460551
160344160344Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis SymptomsCompletedNo Results AvailableSeasonal Allergic RhinitisDietary Supplement: Lectranal|Dietary Supplement: placebohttps://ClinicalTrials.gov/show/NCT00460538
160345160345Phase II AMA-1 Malaria Vaccine FMP2.1/AS02A Trial in MaliCompletedHas ResultsPlasmodium Falciparum MalariaBiological: FMP2.1/AS02A|Biological: Rabies Vaccinehttps://ClinicalTrials.gov/show/NCT00460525
160346160346An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With SchizophreniaActive, not recruitingNo Results AvailableSchizophreniaDrug: Paliperidone ERhttps://ClinicalTrials.gov/show/NCT00460512
160347160347Improving Outcomes In Diabetic Patients During CABG Surgery By Optimizing Glycemic ControlCompletedNo Results AvailableGlycemic ControlDrug: A IV Insulin drip|Drug: B Low Dose GIK|Drug: C High Dose GIKhttps://ClinicalTrials.gov/show/NCT00460499
160348160348Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization ScheduleCompletedNo Results AvailableEncephalitis, Tick-BorneBiological: Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörflhttps://ClinicalTrials.gov/show/NCT00460486
160349160349A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair SurgeryTerminatedNo Results AvailableDeliriumDrug: Dexmedetomidine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00460473
160350160350Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic MalignanciesTerminatedNo Results AvailableLymphomaDrug: AZD4877https://ClinicalTrials.gov/show/NCT00460460

* Görseller ve İçerik tekif hakkına sahip olabilir